MRIdian gives clinicians the confidence to shrink margins while escalating dose and reducing fractions. Patients have more treatment options, better treatment outcomes, reduced toxicity and improved quality of life.
“Cancer doesn’t wait,” said Dr. Daniel Cagney, a radiation oncologist. “Initially in March and April, there were significant unknowns, but we’ve been living with this for a few months. ... I feel very confident that we will provide the best care for patients and it’s safe for them to come into the hospital.”
ViewRay, Inc. announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference. Scott Drake, President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020.
ViewRay, Inc. announced today that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.
A new kind of medical technology company, ViewRay® Inc. designs, manufactures and markets MRIdian – the world’s first MRI-guided radiation therapy system to image and treat cancer patients simultaneously.
Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.